Global Therapeutic Drug Monitoring Markets, 2020-2021 & 2030: Methods for Market Estimation and Future Forecasts According to Point of Application of Tests
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcomes.
TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs.
The TDM market is analyzed from 2020 to 2030 according to technologies as well as geographical distribution. The global market for DoA testing was also analyzed from 2020 to 2030 and divided according to the area of application.
Unmet needs and strategies for the development of markets for TDM are discussed. The report contains profiles of 35 companies involved in developing tests and equipment for drug monitoring along with their collaborations.
Markets for TDM
Methods for market estimation and future forecasts
Global markets for TDM tests
Global markets for TDM according to technologies
Global TDM markets according to drug categories
Agents used for treatment of Alzheimer disease
Analgesics
Anticancer agents
Anticoagulants
Antidepressants
Antiepileptics
Antimicrobials
Antipsychotics
Biological therapies
Bronchodilators
Cardiovascular drugs
Corticosteroids/antihistaminics/antiinflammatory agents
Hypnotic-sedatives
Immunosuppressants
Parkinson disease drugs
Breakdown of global markets according to point of application of tests
Markets for TDM and DoA testing equipment
Geographical distribution of markets for TDM tests
Drivers for growth of TDM markets
Markets for DoA testing
Unmet needs in TDM
Cost-benefit studies
Simplifying assays and reducing time and cost
Strategies for developing markets
Physician education
Supporting research on TDM
Biomarker patents for drug monitoring
Technologies for TDM
Sample preparation
Proteomic technologies
Mass spectrometry
Liquid chromatography MS
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
Combining capillary electrophoresis with MS
Gas-liquid chromatography
Tissue imaging mass spectrometry
New trends in sample preparation
Pressure Cycling Technology
Desorption electrospray ionization imaging
High Performance Liquid Chromatography (HPLC)
Ultra performance LC
Application of HPLC and MS for separation of drug molecules
TDM using dry blood spots
Analysis of dried blood spots for drugs using DESI
Quantitative analysis of drugs in dried blood spot by paper spray MS
TDM in sweat
Immunoassays
Enzyme-linked immunosorbent assay
Cloned Enzyme Donor Immunoassay
Enzyme Multiplied Immunoassay Technique
Fluorescence Polarization Immunoassay
Particle Enhanced Turbidimetric Inhibition Immunoassay
Radioimmunometric assays
Biosensors
Biochips & Microarrays
Introduction
Microchip capillary electrophoresis
Phototransistor biochip biosensor
Microchip-based fluorescence polarization immunoassay for TDM
Cellular microarrays
Microfluidics for TDM
Lab-on-a-chip
Micronics' microfluidic technology
Rheonix CARD technology
Nano-interface in a microfluidic chip
Levitation of nanofluidic drops with physical forces
Nanoarrays
Nanobiotechology
NanoDxT
Biomarkers
Applications of biomarkers in drug safety studies
Genomic technologies for toxicology biomarkers
Proteomic technologies for toxicology biomarkers
Metabonomic technologies for toxicology biomarkers
Integration of genomic and metabonomic data to develop toxicity biomarkers
Toxicology studies based on biomarkers
Biomarkers of hepatotoxicity
Biomarkers of nephrotoxicity
Cardiotoxicity
Neurotoxicity
Biomarkers in clinical trials
Molecular diagnostics
Novel technologies for TDM at point-of-care
NanoEye
Nanobiosensors
Key Topics Covered:
Executive Summary
1. Introduction
2. Technologies for TDM
3. Drug Monitoring Instruments
4. Applications of TDM
5. Drugs Requiring Monitoring
6. Monitoring of Biological Therapies
7. Monitoring of Drug Abuse
8. Markets for TDM
9. Companies
10. References
For more information about this report visit https://www.researchandmarkets.com/r/msyscw
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900